We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

Ganymed Pharmaceuticals Announces CE Marking for Solid Tumour Test

CLAUDETECT™18.2 is the first and only CE marked IVD test specific for the detection of Claudin-18.2 in gastroesophageal, pancreatic and other solid tumors.
News

Broad Institute and Bayer Join Forces

The Broad Institute has entered into a strategic alliance with Bayer Healthcare in the area of oncogenomics and drug discovery.
News

Moving Genes have Scientists Seeing Spots

An international team of scientists has perfected a way of watching genes move within a living plant cell.
News

Vapourtec Pump Key to Organometallic Process

Paper describes a telescoped continuous flow process that produces breast cancer drug Tamoxifen at the rate of one dose every 5 seconds.
News

£25m to Kick-Start ‘Industrial Revolution’ in Regenerative Medicine

Applications will include Parkinson’s disease, cardiovascular disease, wound and musculoskeletal repair, eye disorders and deafness.
News

LFB Inaugurating the CELLforCURE Industrial Facility Manufacturing Cell Therapies

Inauguration attended by Arnaud Montebourg, Minister of Industrial Renewal.
News

Novel Mechanism Discovered in First Line of Immune Defence

Discovery opens doors to developing new therapies to eradicate tumour cells and combat infections.
News

AB SCIEX Proteomics Scientist Wins HUPO 2013 Science and Technology Award

Dr. Christie Hunter is being recognized for her contributions to the development and commercialization of a breakthrough approach for targeted proteomics.
News

Telethon Network of Genetic Biobanks: a Key Service for Diagnosis and Research on Rare Diseases

Recent advances in the technology of molecular biology and genetics have contributed to raise the awareness of the importance of coordinated biobanking activity.
News

Patient Understanding and Awareness of their Roles as Research Stakeholders in a Cancer Biobank

A patient’s informed consent should imply that the patient has received complete information and fully understands its meaning.
Advertisement